The novel toluidine sulphonamide EL102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents MDR1 resistance - Concepedia

Concepedia

Publication | Open Access

The novel toluidine sulphonamide EL102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents MDR1 resistance

DOI Full Paper Access

12

Citations

23

References

2013

Year

Aidan Toner, Fiona McLaughlin, Frank Giles, Francis Sullivan, Enda O’Connell, Laura A. Carleton, Laura Breen, Gráinne Dunne, Adrienne M. Gorman, Joe Lewis,

British Journal of Cancer

References

	Year	Citations

Page 1